semaglutide colombia Novo Nordisk to launch Ozempic for type 2 diabetes in US Novo Nordisk's Wegovy weight-loss drug

However, baseline data often makes follow-up clearer

If you have type 2 diabetes , which Ozempic is FDA-approved to treat, you will likely lose weight slower than those who are taking Ozempic solely to treat their obesity and who do not have type 2 diabetes

Its also important to note that for patients using Wegovy to reduce heart attack and stroke risk, which Australias Therapeutic Goods Administration recently approved it for, theres no evidence that cardiovascular benefits will be achieved at lower-than-recommended doses

La ciruga baritrica sigue siendo el tratamiento ms eficaz para la obesidad grave, pero es probable que el tratamiento evolucione para incluir una nueva combinacin de enfoques en el futuro